Follow
Sanaz Keshavarz Shahbaz
Sanaz Keshavarz Shahbaz
Qazvin University of Medical Science
Verified email at mums.ac.ir
Title
Cited by
Cited by
Year
Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways
K Koushki, SK Shahbaz, K Mashayekhi, M Sadeghi, ZD Zayeri, MY Taba, ...
Clinical reviews in allergy & immunology 60, 175-199, 2021
2242021
Regulatory T cells: possible mediators for the anti-inflammatory action of statins
SK Shahbaz, M Sadeghi, K Koushki, PE Penson, A Sahebkar
Pharmacological Research 149, 104469, 2019
372019
Gold nanoparticles: multifaceted roles in the management of autoimmune disorders
K Koushki, S Keshavarz Shahbaz, M Keshavarz, EE Bezsonov, ...
Biomolecules 11 (9), 1289, 2021
332021
High expression of TIM-3 and KIM-1 in blood and urine of renal allograft rejection patients
SK Shahbaz, F Pourrezagholi, M Barabadi, F Foroughi, M Hosseinzadeh, ...
Transplant Immunology 43, 11-20, 2017
322017
Altered expression of microRNAs following chronic allograft dysfunction with interstitial fibrosis and tubular atrophy
E Soltaninejad, MH Nicknam, M Nafar, MH Sharbafi, SK Shahbaz, ...
Iranian Journal of Allergy, Asthma and Immunology, 615-623, 2015
242015
Dc-specific aptamer decorated gold nanoparticles: A new attractive insight into the nanocarriers for allergy epicutaneous immunotherapy
K Koushki, AR Varasteh, SK Shahbaz, M Sadeghi, K Mashayekhi, ...
International journal of pharmaceutics 584, 119403, 2020
232020
Sublingual dendritic cells targeting by aptamer: Possible approach for improvement of sublingual immunotherapy efficacy
SK Shahbaz, AR Varasteh, K Koushki, SH Ayati, K Mashayekhi, ...
International Immunopharmacology 85, 106603, 2020
222020
PLGA-based curcumin delivery system: An interesting therapeutic approach in the treatment of Alzheimer’s disease
SK Shahbaz, K Koushki, T Sathyapalan, M Majeed, A Sahebkar
Current Neuropharmacology 20 (2), 309, 2022
212022
Application of PLGA nano/microparticle delivery systems for immunomodulation and prevention of allotransplant rejection
S Keshavarz Shahbaz, F Foroughi, E Soltaninezhad, T Jamialahmadi, ...
Expert Opinion on Drug Delivery 17 (6), 767-780, 2020
212020
DC-targeted gold nanoparticles as an efficient and biocompatible carrier for modulating allergic responses in sublingual immunotherapy
M Sadeghi, K Koushki, K Mashayekhi, SH Ayati, SK Shahbaz, ...
International Immunopharmacology 86, 106690, 2020
182020
Inflammasomes and colorectal cancer
SK Shahbaz, K Koushki, SH Ayati, AR Bland, EE Bezsonov, A Sahebkar
Cells 10 (9), 2021
172021
E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy
D Jafari, MJ Mousavi, S Keshavarz Shahbaz, L Jafarzadeh, S Tahmasebi, ...
Clinical & Experimental Immunology 204 (1), 14-31, 2021
152021
Current possibilities and future perspectives for improving efficacy of allergen-specific sublingual immunotherapy
M Sadeghi, SK Shahbaz, S Dehnavi, K Koushki, M Sankian
International Immunopharmacology 101, 108350, 2021
142021
Inflammasomes and colorectal cancer
S Keshavarz Shahbaz, K Koushki, SH Ayati, AR Bland, EE Bezsonov, ...
Cells 10 (9), 2172, 2021
122021
Expression patterns of Toll like receptor (TLR)-2, TLR-4 and myeloid differentiation primary response gene 88 (MYD88) in renal transplant patients developing allograft …
M Hosseinzadeh, P Ahmadpoor, MS Yekaninejad, F Pourrezagholi, ...
Transplant Immunology 48, 26-31, 2018
122018
Dynamic variation of kidney injury molecule-1 mRNA and protein expression in blood and urine of renal transplant recipients: a cohort study
S Keshavarz Shahbaz, F Pourrezagholi, M Nafar, P Ahmadpoor, ...
Clinical and experimental nephrology 23, 1235-1249, 2019
82019
Sequential monitoring of TIM-3 mRNA expression in blood and urine samples of renal transplant recipients
SK Shahbaz, M Barabadi, P Ahmadpour, F Pourrezagholi, M Nafar, ...
Transplant Immunology 54, 9-16, 2019
82019
Recent advances in improving intranasal allergen-specific immunotherapy; focus on delivery systems and adjuvants
M Sadeghi, A Asadirad, K Koushki, SK Shahbaz, S Dehnavi
International Immunopharmacology 113, 109327, 2022
72022
High expression of FOXP3 mRNA in blood and urine as a predictive marker in kidney transplantation
M Barabadi, SK Shahbaz, F Foroughi, M Hosseinzadeh, M Nafar, ...
Progress in Transplantation 28 (2), 134-141, 2018
62018
Increased levels of CD4+ and CD8+ T cells expressing CCR1 in patients developing allograft dysfunction; a cohort study
F Foroughi, A Amirzargar, P Ahmadpoor, F Noorbakhsh, M Nafar, ...
Transplant Immunology 38, 67-74, 2016
52016
The system can't perform the operation now. Try again later.
Articles 1–20